Bplf Medicinal Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.15 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Bplf Medicinal
Bplf Medicinal Private Limited (BMPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2011 and has a history of 13 years and three months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Abul Faizali and Seema Parveen serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191UP2011PTC047246
-
Company No.
047246
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Nov 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Bplf Medicinal?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abul Faizali
|
Director | 02-Nov-2011 | Current |
|
Seema Parveen
|
Director | 02-Nov-2011 | Current |
Financial Performance of Bplf Medicinal.
Bplf Medicinal Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bplf Medicinal?
In 2017, Bplf Medicinal had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rassone Infra LlpAbul Faizali is a mutual person
-
Logigo Gateway Llp
Abul Faizali is a mutual person
-
Hhd Ventures Llp
Abul Faizali is a mutual person
-
Padmawati Real Estate Private Limited
Abul Faizali is a mutual person
-
Bplf Infradevelopers Private Limited
Abul Faizali and Seema Parveen are mutual person
-
Bplf Infraestate Private Limited
Abul Faizali is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bplf Medicinal?
Unlock and access historical data on people associated with Bplf Medicinal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bplf Medicinal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bplf Medicinal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
